SCHEMBL2430751

SCHEMBL2430751

Fc1ccc(-c2ccc[c]c2Cl)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 4/20 0.39
PTGS1 P23219 1/20 0.39
SLC6A4 P31645 1/20 0.36
SLC6A3 Q01959 1/20 0.36
NR4A2 P43354 1/20 0.35
HTR7 P34969 1/20 0.35
ALDH1A3 P47895 1/20 0.35
RPS6KA3 P51812 2/20 0.34
MAPK14 Q16539 2/20 0.34
DAPK3 O43293 1/20 0.34
PRKD3 O94806 1/20 0.34
MAP4K4 O95819 1/20 0.34
PAK4 O96013 1/20 0.34
ABL1 P00519 1/20 0.34
NTRK1 P04629 1/20 0.34
LCK P06239 1/20 0.34
CSF1R P07333 1/20 0.34
RET P07949 1/20 0.34
IGF1R P08069 1/20 0.34
MET P08581 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2011820 0.84 GRM5 (0.32) HTR7MET
SCHEMBL435264 0.83 CYP1A2 (0.42) PTGS2PTGS1SLC6A4SLC6A3ALDH1A3
SCHEMBL3978906 0.83 CYP2A6 (0.50) PTGS2PTGS1ALDH1A3RPS6KA3RET
SCHEMBL2429097 0.81 TAAR1 (0.43) HTR7MAP4K4PRKACAGSK3BCLK4
SCHEMBL4281566 0.81 CYP2A6 (0.48) PTGS2ALDH1A3MAP4K4SMN1; SMN2ALDH1A1
SCHEMBL9788256 0.81 PTGS2 (0.40) PTGS2PTGS1SLC6A4SLC6A3NR4A2
SCHEMBL5584101 0.79 IDO1 (0.32) CYP2A6
SCHEMBL4394322 0.79 CYP2A6 (0.32) CYP2A6
SCHEMBL9667400 0.79 MAPK1 (0.39) SLC6A3MAPK14LCKCSF1RFGFR1
SCHEMBL6881481 0.79 HPGD (0.36) ALDH1A1NPC1RAB9AHSD17B10CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005103015-A1 TRIAZINE COMPOUNDS AND THEIR ANALOGS, COMPOSITIONS, AND METHODS REDDY US THERAPEUTICS, INC. (US) 2005-11-03 WO claimed
WO-2005014534-A1 ARYL AND HETEROARYL COMPOUNDS, COMPOSITIONS, AND METHODS OF USE TRANSTECH PHARMA, INC. (US) 2005-02-17 WO claimed
WO-2013182433-A1 A PROCESS USING GRIGNARD REAGENTS BASF SE (DE) 2013-12-12 WO disclosed
EP-2547687-A1 A PROCESS USING GRIGNARD REAGENTS BASF SE (DE) 2013-01-23 EP disclosed
EP-2513067-A1 METHOD FOR PRODUCING TRIAZOLINTHIONE DERIVATIVES AND INTERMEDIATES THEREOF BASF SE (DE) 2012-10-24 EP disclosed
WO-2011113820-A1 A PROCESS USING GRIGNARD REAGENTS BASF SE (DE) 2011-09-22 WO disclosed
WO-2005103015-A1 TRIAZINE COMPOUNDS AND THEIR ANALOGS, COMPOSITIONS, AND METHODS REDDY US THERAPEUTICS, INC. (US) 2005-11-03 WO disclosed
US-5104438-A N-OXOAZOLYLMETHYLOXIRANES AND FUNGICIDES AND BIOREGULATORS CONTAINING THEM BASF AKTIENGESELLSCHAFT (DE) 1992-04-14 US disclosed
US-4216232-A Pharmaceutical compositions BEECHAM GROUP LIMITED (GB) 1980-08-05 US disclosed